The scientist’s investigation covers issues in Stroke, Internal medicine, Cardiology, Perfusion scanning and Surgery. His studies deal with areas such as Tissue plasminogen activator and Randomized controlled trial as well as Stroke. Christopher R. Levi works mostly in the field of Internal medicine, limiting it down to topics relating to Gastroenterology and, in certain cases, Genetic variation.
Christopher R. Levi is researching Perfusion scanning as part of the investigation of Perfusion and Radiology. Christopher R. Levi interconnects Desmoteplase, Nuclear medicine, Angiography, Acute stroke and Penumbra in the investigation of issues within Perfusion. Christopher R. Levi combines subjects such as Transcranial Doppler, Vascular dementia and Normal pressure hydrocephalus with his study of Surgery.
Stroke, Internal medicine, Cardiology, Thrombolysis and Surgery are his primary areas of study. His Stroke research includes elements of Randomized controlled trial, Perfusion, Perfusion scanning and Emergency medicine. The various areas that he examines in his Perfusion scanning study include Infarction, Cerebral blood flow and Penumbra.
When carried out as part of a general Internal medicine research project, his work on Tissue plasminogen activator, Odds ratio, Brain ischemia and Prospective cohort study is frequently linked to work in Genome-wide association study, therefore connecting diverse disciplines of study. His research in Cardiology intersects with topics in Cerebral infarction and Acute ischemic stroke. The Thrombolysis study combines topics in areas such as Reperfusion therapy, Anesthesia, Fibrinolytic agent and Acute stroke.
Christopher R. Levi mainly focuses on Stroke, Internal medicine, Thrombolysis, Cardiology and Modified Rankin Scale. His Stroke research includes elements of Odds ratio, Randomized controlled trial, Perfusion scanning and Emergency medicine. The study incorporates disciplines such as Diabetes mellitus and Oncology in addition to Internal medicine.
He has researched Thrombolysis in several fields, including Reperfusion therapy, Interquartile range, Blood pressure, Cluster randomised controlled trial and Fibrinolytic agent. His biological study spans a wide range of topics, including Confounding, Neurology and Cohort. His Modified Rankin Scale research is multidisciplinary, incorporating perspectives in Occlusion, Brain ischemia and Asymptomatic.
Christopher R. Levi mainly investigates Stroke, Internal medicine, Modified Rankin Scale, Randomized controlled trial and Thrombolysis. His research in Stroke is mostly concerned with Fibrinolytic agent. His Internal medicine research integrates issues from Oncology and Cardiology.
Christopher R. Levi interconnects Meta-analysis, Occlusion and Brain ischemia in the investigation of issues within Modified Rankin Scale. His study in Randomized controlled trial is interdisciplinary in nature, drawing from both Anesthesia, Clinical trial and Dissection. In his study, Perfusion is inextricably linked to Placebo, which falls within the broad field of Odds ratio.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial.
Stephen M Davis;Geoffrey A Donnan;Mark W Parsons;Christopher Levi.
Lancet Neurology (2008)
A randomized trial of tenecteplase versus alteplase for acute ischemic stroke.
Mark Parsons;Neil Spratt;Andrew Bivard;Bruce Campbell.
The New England Journal of Medicine (2012)
Genetic risk factors for ischaemic stroke and its subtypes (the METASTROKE collaboration): a meta-analysis of genome-wide association studies.
Matthew Traylor;Martin Farrall;Elizabeth G Holliday;Cathie Sudlow.
Lancet Neurology (2012)
The independent predictive utility of computed tomography angiographic collateral status in acute ischaemic stroke
Ferdinand Miteff;Christopher R. Levi;Christopher R. Levi;Grant A. Bateman;Neil Spratt;Neil Spratt.
Tenecteplase versus Alteplase before Thrombectomy for Ischemic Stroke
Bruce C.V. Campbell;Peter J. Mitchell;Leonid Churilov;Nawaf Yassi.
The New England Journal of Medicine (2018)
Antiplatelet treatment compared with anticoagulation treatment for cervical artery dissection (CADISS): a randomised trial
Cadiss trial investigators;Hugh S Markus;Elizabeth Hayter;Christopher Levi.
Lancet Neurology (2015)
Knowledge of Stroke Risk Factors, Warning Symptoms, and Treatment Among an Australian Urban Population
Sung Sug Yoon;Richard F. Heller;Christopher Levi;John Wiggers.
Implementation of evidence-based treatment protocols to manage fever, hyperglycaemia, and swallowing dysfunction in acute stroke (QASC): a cluster randomised controlled trial
Sandy Middleton;Sandy Middleton;Patrick McElduff;Jeanette Ward;Jeremy M Grimshaw.
Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke
C Bellenguez;S Bevan;A Gschwendtner;Spencer Cca..
Nature Genetics (2012)
Cerebral Blood Flow Is the Optimal CT Perfusion Parameter for Assessing Infarct Core
Bruce C.V. Campbell;Søren Christensen;Christopher R. Levi;Patricia M. Desmond.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: